review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Xiaohua Li | |
David R Hinton | |||
Shikun He | |||
Nymph Chan | |||
P2860 | cites work | Apolipoprotein J inhibits the migration and adhesion of endothelial cells. | Q50504280 |
Epigenetics of embryonic stem cells. | Q51798781 | ||
Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells | Q58325456 | ||
Methylation of CpG island promoters in uveal melanoma | Q80530973 | ||
Promoter methylation status of multiple genes in uveal melanoma | Q81358040 | ||
Therapeutic potential of valproic acid for retinitis pigmentosa | Q84582883 | ||
Epigenetics and cardiovascular disease | Q85768193 | ||
MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells | Q21135545 | ||
The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain | Q22065852 | ||
An integrated encyclopedia of DNA elements in the human genome | Q22122150 | ||
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 | Q24316558 | ||
Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma | Q24606279 | ||
The role of epigenetics in the pathology of diabetic complications | Q24609124 | ||
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine | Q24614582 | ||
MicroRNAs regulate ocular neovascularization | Q24631030 | ||
Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA | Q24632387 | ||
Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway | Q24634357 | ||
Mechanisms of age-related macular degeneration | Q27000182 | ||
MicroRNA-target interactions: new insights from genome-wide approaches | Q27000642 | ||
Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity | Q28274440 | ||
Silencing of Fem1cR3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity | Q28506707 | ||
Chromatin remodeling enzyme Brg1 is required for mouse lens fiber cell terminal differentiation and its denucleation | Q28588453 | ||
Functions of DNA methylation: islands, start sites, gene bodies and beyond | Q29547260 | ||
Cancer epigenetics: from mechanism to therapy | Q29614799 | ||
Epigenetic modifications and human disease | Q29619753 | ||
Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes | Q33347134 | ||
Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis | Q33588162 | ||
MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis | Q33643242 | ||
Epigenetic regulation of latent HSV-1 gene expression | Q33729340 | ||
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome | Q33741025 | ||
DNA methylation is associated with altered gene expression in AMD. | Q33939754 | ||
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes | Q33941116 | ||
Inhibition of histone deacetylase protects the retina from ischemic injury | Q33994208 | ||
Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon | Q34009114 | ||
Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells | Q34194436 | ||
Epigenomics reveals a functional genome anatomy and a new approach to common disease | Q34207844 | ||
Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. | Q34221312 | ||
Histone deacetylase: a potential therapeutic target for fibrotic disorders | Q34257607 | ||
Epigenetic regulation of the immune system in health and disease | Q37807995 | ||
Epigenetic mechanisms in inflammation | Q37823067 | ||
Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s | Q37823851 | ||
Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis? | Q37865848 | ||
Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs | Q37878207 | ||
Epigenetics: new questions on the response to hypoxia | Q37918376 | ||
An epigenetic approach toward understanding ocular α-herpesvirus pathogenesis and treatment. | Q37928331 | ||
Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases | Q38018832 | ||
MicroRNAs in cancers and neurodegenerative disorders | Q38051332 | ||
Long noncoding RNAs in cardiac development and pathophysiology | Q38056111 | ||
Epigenetic inactivation of RASSF1a in uveal melanoma. | Q38434326 | ||
The role of RASSF1A in uveal melanoma | Q39373975 | ||
A novel retinoblastoma therapy from genomic and epigenetic analyses | Q39413689 | ||
Status of RASSF1A in uveal melanocytes and melanoma cells. | Q39501081 | ||
MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats | Q39557657 | ||
Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation | Q39738064 | ||
Effect of Smad7 gene overexpression on transforming growth factor beta-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse model | Q40132971 | ||
Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa | Q40150974 | ||
Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells | Q40251101 | ||
The inhibition of angiogenesis by antisense oligonucleotides to clusterin | Q40347656 | ||
A role for DNA methylation in regulation of EphA5 receptor expression in the mouse retina | Q41853631 | ||
Selective transcription and cellular proliferation induced by PDGF require histone deacetylase activity | Q42804078 | ||
Epigenetic treatments of adult rats promote recovery from visual acuity deficits induced by long-term monocular deprivation | Q43021329 | ||
Methylation status of RASSF1A and DAPK promoter in retinoblastoma | Q43231036 | ||
Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells | Q43244783 | ||
Altered microRNA expression profiles in retinas with diabetic retinopathy | Q43894251 | ||
Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines | Q44453093 | ||
Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. | Q45921402 | ||
Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease | Q34289150 | ||
Histone deacetylases and cancer. | Q34298745 | ||
Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells | Q34338452 | ||
Regulated nucleosome mobility and the histone code. | Q34364723 | ||
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. | Q34488424 | ||
Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse. | Q34545446 | ||
A twin approach to unraveling epigenetics | Q34713637 | ||
MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy | Q34718910 | ||
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration | Q34796058 | ||
Cataracts associated with systemic disorders and syndromes | Q35004228 | ||
Dark matters in AMD genetics: epigenetics and stochasticity | Q35005822 | ||
MicroRNA-mediated posttranscriptional regulation is required for maintaining undifferentiated properties of blastoderm and primordial germ cells in chickens | Q35081691 | ||
Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy. | Q35092187 | ||
Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2. | Q35531772 | ||
SirT1--a sensor for monitoring self-renewal and aging process in retinal stem cells. | Q35638950 | ||
Advances in epigenetics and epigenomics for neurodegenerative diseases | Q35709124 | ||
DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients | Q35874941 | ||
Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina | Q35886487 | ||
Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD) | Q35887465 | ||
A unique regulatory phase of DNA methylation in the early mammalian embryo | Q35903352 | ||
Basic concepts of epigenetics: impact of environmental signals on gene expression | Q35911124 | ||
The genetic and epigenetic journey of embryonic stem cells into mature neural cells. | Q35969352 | ||
Experimental murine myopia induces collagen type Iα1 (COL1A1) DNA methylation and altered COL1A1 messenger RNA expression in sclera. | Q36015813 | ||
SNP rs1533428 at 2p16.3 as a marker for late-onset primary open-angle glaucoma. | Q36073878 | ||
Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics | Q36405448 | ||
Hypomethylation of the IL17RC promoter associates with age-related macular degeneration | Q36442673 | ||
Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. | Q36693824 | ||
Epigenetics in inflammatory rheumatic diseases | Q36985127 | ||
Histone modifications and chromatin remodeling during bacterial infections | Q37240625 | ||
Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis | Q37310665 | ||
Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation | Q37468782 | ||
Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD). | Q37546290 | ||
Epigenetics and gene expression | Q37749500 | ||
Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters | Q37791990 | ||
Epigenetic regulation of aging. | Q37793425 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | regulation of gene expression | Q411391 |
eye disease | Q3041498 | ||
genetic epigenesis | Q64443099 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 665-674 | |
P577 | publication date | 2013-03-21 | |
P1433 | published in | Molecular Vision | Q6895981 |
P1476 | title | Review: Epigenetic mechanisms in ocular disease | |
P478 | volume | 19 |
Q33784315 | Altered bioenergetics and enhanced resistance to oxidative stress in human retinal pigment epithelial cells from donors with age-related macular degeneration |
Q35679227 | An activated unfolded protein response promotes retinal degeneration and triggers an inflammatory response in the mouse retina |
Q89767028 | Chromatin remodeling protein HELLS is critical for retinoblastoma tumor initiation and progression |
Q41717727 | DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders |
Q35017752 | Diabetes and retinal vascular dysfunction |
Q37280210 | Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy |
Q38244141 | Epigenetic modifications and potential new treatment targets in diabetic retinopathy |
Q64109825 | Epigenetically dysregulated genes and pathways implicated in the pathogenesis of non-syndromic high myopia |
Q39140153 | Epigenetics and Signaling Pathways in Glaucoma |
Q48097604 | Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury |
Q36129769 | Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia |
Q64052110 | Identification of altered microRNAs in retinas of mice with oxygen-induced retinopathy |
Q37612377 | Instability in X chromosome inactivation patterns in AMD: a new risk factor? |
Q38173896 | Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. |
Q38170901 | Mobilizing endogenous stem cells for retinal repair |
Q93184233 | Modulating Ocular Scarring in Glaucoma Filtration Surgery Using the Epigenetic Adjunct Suberoylanilide Hydroxamic Acid |
Q35577823 | Molecular mechanisms of subretinal fibrosis in age-related macular degeneration. |
Q89687599 | Polypoidal Choroidal Vasculopathy in Congolese Patients |
Q34411723 | Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients |
Q38963936 | Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine |
Q38252350 | The role of epigenetics in age-related macular degeneration |
Q28393006 | Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy |
Q91717473 | Tumour Expression of Histone Deacetylases in Uveal Melanoma |
Search more.